Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01410123 · ClinicalTrials.gov registry record · NA

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

A NA study of HIV and Hepatitis C, sponsored by Yale University.

Completed
Registry status
NA
Development phase
319
Enrollment target
5
Study locations

NCT01410123 is a NA study of HIV and Hepatitis C that has completed, run by Yale University. The registered enrollment target is 319 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (27% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01410123, a NA study of HIV and Hepatitis C, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
319 participants
Enrollment target
5
Study locations

Study Summary

The study is a series of 3 linked randomized clinical trials of 6 month duration, with a total of 12 month follow-up, to evaluate the effect of Integrated Stepped Care on drinking outcomes and HIV biologic markers (including VACS index) in HIV-infected patients with unhealthy alcohol use.

Interventions

  • OTHER Treatment as Usual
  • OTHER Integrated Stepped Care (ISC)

Study Locations (5)

Texas

  • Dallas VA Medical Center - Dallas
  • VAMC Houston - Houston

District of Columbia

  • Washington DC VAMC - Washington D.C.

Georgia

  • VAMC Atlanta - Atlanta

New York

  • New York VAMC - New York Harbor Healthcare System - New York

Trial Details

FieldValue
Enrollment Target 319 participants
Start Date 2013-01
Est. Completion 2018-08-31
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT01410123

The ClinicalTrials.gov registry entry for NCT01410123 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 319 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (27% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT01410123 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Texas, District of Columbia, Georgia.

Frequently Asked Questions

What is clinical trial NCT01410123 about?

NCT01410123 is a clinical study titled "Integrated Stepped Care for Unhealthy Alcohol Use in HIV". The study is a series of 3 linked randomized clinical trials of 6 month duration, with a total of 12 month follow-up, to evaluate the effect of Integrated Stepped Care on drinking outcomes and HIV biologic markers (including VACS index) in HIV-infected patients with unhealthy alcohol use.

What is the current status of trial NCT01410123?

This trial is currently completed. It is a NA study. The enrollment target is 319 participants. The study started on 2013-01. Estimated completion is 2018-08-31.

What conditions does trial NCT01410123 study?

This clinical trial studies the following conditions: HIV, Hepatitis C, Alcoholism, Liver Diseases, Alcoholic.

What interventions are being tested in trial NCT01410123?

The interventions under investigation include: Treatment as Usual (OTHER), Integrated Stepped Care (ISC) (OTHER).

Who is sponsoring clinical trial NCT01410123?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01410123 being conducted?

This trial has 5 study locations across District of Columbia, Georgia, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.